Bickerdike; Michael John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bickerdike; Michael John.The latest application filed is for "bicyclic compounds and methods for their use in treating autistic disorder and autism".

Company Profile

2.10.12

Bickerdike; Michael John - Auckland NZ
Bickerdike; Michael John - Winnersh GB
Bickerdike; Michael John - Wokingham GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclic compounds and methods for their use in treating autism Grant 11,197,856 - Glass , et al. December 14, 2	2021-12-14
Bicyclic Compounds and Methods for Their Use in Treating Autistic Disorder and Autism App 20200163961 - Glass; Lawrence Irwin ; et al.	2020-05-28
Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders Grant 10,548,892 - Glass , et al. Fe	2020-02-04
Neuroprotective Bicyclic Compounds and Methods for Their Use in Treating Autism Spectrum Disorders and Neurodevelopmental Disorders App 20180140601 - Glass; Lawrence Irwin ; et al.	2018-05-24
Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders Grant 9,867,823 - Glass , et al. January 16, 2	2018-01-16
Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate Grant 9,708,366 - Glass , et al. July 18, 2	2017-07-18
Neuroprotective Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders App 20170020869 - Glass; Lawrence Irwin ; et al.	2017-01-26
Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid Grant 9,212,204 - Glass , et al. December 15, 2	2015-12-15
Cyclic Glycyl-2-allyl Proline Improves Cognitive Performance In Impaired Animals App 20150258091 - Bickerdike; Michael John ; et al.	2015-09-17
Cyclic Glycyl-2-Allyl Proline improves cognitive performance in impaired animals Grant 9,119,851 - Bickerdike , et al. September 1, 2	2015-09-01
Treatment Of Autism Spectrum Disorders Using Glycyl-l-2-methylprolyl-l-glumatic Acid App 20150224164 - Glass; Lawrence Irwin ; et al.	2015-08-13
Treatment of Autism Spectrum Disorders Using Glycyl-L-2-Methylprolyl-L-Glutamic Acid App 20150197543 - Glass; Lawrence Irwin ; et al.	2015-07-16
Cyclic Glycyl-2-Allyl Proline Improves Cognitive Performance in Impaired Animals App 20140309230 - Bickerdike; Michael John ; et al.	2014-10-16
Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals Grant 8,791,117 - Bickerdike , et al. July 29, 2	2014-07-29
Treatment Of Autism Spectrum Disorders Using Glycyl-l-2-methylprolyl-l-glutamic Acid App 20140147491 - Glass; Larry ; et al.	2014-05-29
Cyclic Glycyl-2-allyl Proline Improves Cognitive Performance In Impaired Animals App 20110201614 - Bickerdike; Michael John	2011-08-18
Use of azetidinecarboxamide derivatives in therapy App 20060276452 - Davidson; James ; et al.	2006-12-07
Fused indole derivatives Grant 6,610,685 - Bentley , et al. August 26, 2	2003-08-26
Novel indole derivatives App 20020160997 - Bentley, Jonathan Mark ; et al.	2002-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.